[{"id":"ef8c69f2-9cbe-4385-a557-591f47dd7101","acronym":"","url":"https://clinicaltrials.gov/study/NCT03381274","created_at":"2021-01-18T16:41:08.185Z","updated_at":"2024-07-02T16:34:37.847Z","phase":"Phase 1/2","brief_title":"Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study","source_id_and_acronym":"NCT03381274","lead_sponsor":"MedImmune LLC","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR T790M negative","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR T790M negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tagrisso (osimertinib) • oleclumab (MEDI9447) • imaradenant (AZD4635)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 43","initiation":"Initiation: 05/08/2018","start_date":" 05/08/2018","primary_txt":" Primary completion: 05/24/2021","primary_completion_date":" 05/24/2021","study_txt":" Completion: 07/15/2025","study_completion_date":" 07/15/2025","last_update_posted":"2024-06-06"},{"id":"bd4c0ff9-06d4-4a21-b139-a7ee3b5948c4","acronym":"","url":"https://clinicaltrials.gov/study/NCT02740985","created_at":"2021-01-18T13:25:31.246Z","updated_at":"2024-07-02T16:35:47.034Z","phase":"Phase 1","brief_title":"A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies","source_id_and_acronym":"NCT02740985","lead_sponsor":"AstraZeneca","biomarkers":" EGFR • ALK","pipe":" | ","alterations":" EGFR mutation • MSI-H/dMMR • ALK rearrangement","tags":["EGFR • ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • MSI-H/dMMR • ALK rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Imfinzi (durvalumab) • docetaxel • Xtandi (enzalutamide) • abiraterone acetate • dexamethasone • oleclumab (MEDI9447) • imaradenant (AZD4635)"],"overall_status":"Completed","enrollment":" Enrollment 313","initiation":"Initiation: 06/17/2016","start_date":" 06/17/2016","primary_txt":" Primary completion: 12/31/2020","primary_completion_date":" 12/31/2020","study_txt":" Completion: 03/31/2023","study_completion_date":" 03/31/2023","last_update_posted":"2023-05-26"}]